Physician

Adam Ryan Thode, M.D.

According to 2025 Medicare claims, Adam Thode, M.D. (NPI: 1063738987) practices ophthalmology in the Lancaster, PA market, with the plurality of this provider's patient population coming from Lancaster, PA. This provider's primary affiliated billing organization is FRANCIS J MANNING MD PC (NPI: 1720005465; TIN: 522406923) and primary practice location at 17603-7600. Thode is affiliated with the Lancaster General Health Community Care Collaborative, LLC (ACO ID: A2019), participating under the MSSP model.

Thode's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,744 traditional Medicare patients, billed 4,415 HCPCS/CPT codes, and received $417,005 in Medicare payments. The top billing code was 66984 (Removal of cataract with insertion of prosthetic lens). Part D data shows 1,692 prescription claims across 407 beneficiaries totaling $296,382 in drug costs, led by Lumigan (Bimatoprost). DME data shows 285 claims. Open Payments data shows 23 records totaling $576. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $59,216 to $417,005. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $65,437 to $296,382. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	231	537	$59,216
2016	542	1,413	$142,483
2017	686	1,681	$169,981
2018	835	1,903	$208,217
2019	1,003	2,567	$275,255
2020	962	2,434	$262,309
2021	1,276	3,398	$369,683
2022	1,457	3,757	$376,997
2023	1,668	4,217	$411,189
2024	1,744	4,415	$417,005

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	128	429	$65,437
2016	166	452	$71,540
2017	167	502	$66,049
2018	189	654	$110,914
2019	245	885	$355,907
2020	262	909	$195,593
2021	326	1,240	$306,783
2022	387	1,552	$471,311
2023	413	1,604	$314,995
2024	407	1,692	$296,382

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$515
2016	45	49	$2,867
2017	36	38	$2,434
2018	46	48	$3,034
2019	150	172	$12,170
2020	196	213	$15,172
2021	260	288	$21,045
2022	292	325	$23,925
2023	262	293	$23,857
2024	265	285	$23,810

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
66984	Removal of cataract with insertion of prosthetic lens	330	627	$277
92014	Established patient complete exam of visual system	1,340	1,438	$75
92012	Established patient problem focused exam of visual system	371	516	$56
92083	Exam of visual field with extended testing	317	337	$41
92133	Imaging of optic nerve	291	296	$23

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lumigan	Bimatoprost	89	5,245	$46,125
Combigan	Brimonidine Tartrate/Timolol	97	4,348	$34,442
Restasis	Cyclosporine	30	1,620	$33,221
Xdemvy	Lotilaner	14	644	$25,211
Cyclosporine	Cyclosporine	25	1,590	$20,681

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
V2020	Frames, purchases	N	109	128	$6,925
V2303	Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, .12-2.00d cylinder, per lens	N	53	53	$6,321
V2200	Sphere, bifocal, plano to plus or minus 4.00d, per lens	N	29	30	$3,362
V2100	Sphere, single vision, plano to plus or minus 4.00, per lens	N	29	29	$2,477
V2300	Sphere, trifocal, plano to plus or minus 4.00d, per lens	N	18	18	$2,053

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	23	$576	Tarsus Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam Ryan Thode, M.D.?

Tedicare shows public-source Medicare data for Adam Ryan Thode, M.D. (NPI 1063738987), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Ryan Thode, M.D. have ACO affiliation data?

Adam Ryan Thode, M.D. is shown with ACO affiliation data for Lancaster General Health Community Care Collaborative, LLC (MSSP, ACO ID A2019).

What billing organization is linked to Adam Ryan Thode, M.D.?

Adam Ryan Thode, M.D. is linked to FRANCIS J MANNING MD PC (billing NPI 1720005465) in the available physician profile data.

Does Adam Ryan Thode, M.D. have Open Payments data?

Adam Ryan Thode, M.D. has 23 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.